Biosenic SA
0,0060
10-января-25 05:19:19
15 мин. задержка
Акции
+0,0002
+3,45%
Сегодняшний диапазон
0,0059 - 0,0060
ISIN
BE0974280126
Источник
Cboe
- Котировки
- Графики
Новости
- Статистика
-
31 май 2022 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics enters into exclusive reverse merger discussions with Medsenic
12 май 2022 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics to host Annual General Meeting and Extraordinary General Meeting on 8 June 2022
09 май 2022 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics announces 2021 full year results
29 апр 2022 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics Secures EUR 5 Million Financing
12 апр 2022 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics to strategically focus on lead cell therapy product ALLOB
29 мар 2022 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics SA: Transparency notification received from Nyenburgh Holding NV
23 мар 2022 02:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics provides fourth quarter 2021 business update and 2022 outlook
19 янв 2022 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics SA: Transparency notification received from S.R.I.W. SA and Sofipôle SA
23 дек 2021 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics SA: Transparency notification received from Nyenburgh Holding NV
10 дек 2021 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics SA: Information on the total number of voting rights and shares
09 дек 2021 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics announces closing of private placement
08 дек 2021 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement
03 дек 2021 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB
29 ноя 2021 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics Provides Third Quarter 2021 Business Update
26 окт 2021 01:00:00 Источник Nasdaq GlobeNewswire
-
12 окт 2021 01:00:00 Источник Nasdaq GlobeNewswire
-
28 сен 2021 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer
21 сен 2021 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics reports half year 2021 results
08 сен 2021 01:00:00 Источник Nasdaq GlobeNewswire
-
Bone Therapeutics SA reacts to the press release issued by Hybrigenics
07 сен 2021 01:00:00 Источник Nasdaq GlobeNewswire